Caveolin 3 Antikörper

Produktnummer ABIN2463712

Produktdetails anti-Caveolin 3 Antikörper

Target: Caveolin 3 (CAV3)

Reaktivität: Human, Hund

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Caveolin 3 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Aufreinigung: Antibody is purified by peptide affinity chromatography method.

Immunogen: Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human CAV3.

Anwendungsinformationen

Applikationshinweise: CAV3 antibody can be used for detection of CAV3 by ELISA at 1:12500. CAV3 antibody can be used for detection of CAV3 by western blot at 0.5 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Add 50 ?L of distilled water. Final antibody concentration is 1 mg/mL.

Konzentration: 1 mg/mL

Buffer: Antibody is lyophilized in PBS buffer with 2 % sucrose.

Handhabung: As with any antibody avoid repeat freeze-thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: For short periods of storage (days) store at 4 °C. For longer periods of storage, store CAV3 antibody at -20 °C.

Details zu Caveolin 3

Target: Caveolin 3 (CAV3)

Andere Bezeichnung: CAV3 (CAV3 Produkte)

Synonyme: LGMD1C antikoerper, LQT9 antikoerper, VIP-21 antikoerper, VIP21 antikoerper, AI385751 antikoerper, Cav-3 antikoerper, M-cav antikoerper, caveolin-3 antikoerper, im:6902906 antikoerper, zgc:109710 antikoerper, LOC733765 antikoerper, CAV3 antikoerper, cav3 antikoerper, caveolin 3 antikoerper, caveolin-3 antikoerper, CAV3 antikoerper, Cav3 antikoerper, cav3 antikoerper, LOC733765 antikoerper, cav-3 antikoerper

Hintergrund: CAV3 is a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites.

Molekulargewicht: 17 kDa

Gen-ID: 859

NCBI Accession: NP_001225

UniProt: P56539

Pathways: Carbohydrate Homeostasis, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Skeletal Muscle Fiber Development, Negative Regulation of Transporter Activity